Funds · LABT

Who owns LABT?

No institutional manager reported a Lakewood-Amedex Biotherapeutics Inc. position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

LABT news and filings · Top funds